ZA9810759B - Proliferatively active product for treating proliferating cells. - Google Patents

Proliferatively active product for treating proliferating cells.

Info

Publication number
ZA9810759B
ZA9810759B ZA9810759A ZA9810759A ZA9810759B ZA 9810759 B ZA9810759 B ZA 9810759B ZA 9810759 A ZA9810759 A ZA 9810759A ZA 9810759 A ZA9810759 A ZA 9810759A ZA 9810759 B ZA9810759 B ZA 9810759B
Authority
ZA
South Africa
Prior art keywords
proliferating cells
active product
proliferatively active
treating proliferating
treating
Prior art date
Application number
ZA9810759A
Inventor
Christopher Ralph Franks
Ruggero Della Bitta
Original Assignee
Bioinnovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioinnovation Ltd filed Critical Bioinnovation Ltd
Publication of ZA9810759B publication Critical patent/ZA9810759B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/642—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a cytokine, e.g. IL2, chemokine, growth factors or interferons being the inactive part of the conjugate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
ZA9810759A 1997-11-26 1998-11-25 Proliferatively active product for treating proliferating cells. ZA9810759B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9724838.9A GB9724838D0 (en) 1997-11-26 1997-11-26 Compositions

Publications (1)

Publication Number Publication Date
ZA9810759B true ZA9810759B (en) 2000-05-25

Family

ID=10822573

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9810759A ZA9810759B (en) 1997-11-26 1998-11-25 Proliferatively active product for treating proliferating cells.

Country Status (8)

Country Link
EP (1) EP1032427A2 (en)
JP (1) JP2001523731A (en)
AU (1) AU1249999A (en)
CA (1) CA2311733A1 (en)
GB (1) GB9724838D0 (en)
NZ (1) NZ504625A (en)
WO (1) WO1999026660A2 (en)
ZA (1) ZA9810759B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1185304A2 (en) * 1999-06-03 2002-03-13 Bioinnovation Limited Conjugates comprising cytokines and nucleic acids for treating proliferating cells
US7868011B2 (en) 2003-04-09 2011-01-11 General Atomics Use of reversible inhibitors of S-adenosyl-L-homocysteine hydrolase for treating lupus
US7196093B2 (en) 2003-04-09 2007-03-27 General Atomics Reversible inhibitors of SAH hydrolase and uses thereof
US7517887B2 (en) * 2003-04-09 2009-04-14 General Atomics Reversible inhibitors of S-adenosyl-L-homocysteine hydrolase and uses thereof
EP3766513A1 (en) 2011-03-11 2021-01-20 Assistance Publique Hôpitaux de Paris Use of low dosage il-2 for treating vasculitis
BR112013023151A2 (en) 2011-03-11 2020-09-15 Assistance Publique - Hôpitaux De Paris interleukin-2 for use in the treatment of autoimmune, immune-related or inflammatory disorder and method for determining whether a regimen or dose of il-2 needs to be modified

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318948B1 (en) * 1987-12-02 1992-08-19 Neorx Corporation Cleavable immunoconjugates for the delivery and release of agents in native form
CA2016584C (en) * 1989-05-17 1999-06-29 Robert S. Greenfield Anthracycline conjugates having a novel linker and methods for their production
JP3105629B2 (en) * 1991-04-23 2000-11-06 サングスタット メディカル コーポレイション Cell activity regulating conjugates of members of specific binding pairs
US5248499A (en) * 1991-10-07 1993-09-28 Genentech, Inc. Control of microbial infections in transplant patients
US6214345B1 (en) * 1993-05-14 2001-04-10 Bristol-Myers Squibb Co. Lysosomal enzyme-cleavable antitumor drug conjugates
US5635599A (en) * 1994-04-08 1997-06-03 The United States Of America As Represented By The Department Of Health And Human Services Fusion proteins comprising circularly permuted ligands

Also Published As

Publication number Publication date
JP2001523731A (en) 2001-11-27
WO1999026660A3 (en) 1999-10-14
WO1999026660A2 (en) 1999-06-03
GB9724838D0 (en) 1998-01-21
CA2311733A1 (en) 1999-06-03
EP1032427A2 (en) 2000-09-06
NZ504625A (en) 2002-12-20
AU1249999A (en) 1999-06-15

Similar Documents

Publication Publication Date Title
ZA9610870B (en) Electroconversion cell.
HK1040161A1 (en) Synergistic insecticide mixturesantisense oligonucleotides for treating proliferating cells
ZA9811075B (en) Absorbent article.
SG63814A1 (en) Thin type cell
ZA967387B (en) Absorbent products.
ZA992549B (en) Incorporation of active substances in carrier matrixes.
GB2324408A8 (en) Forming DRAM cells
ZA965381B (en) Electrochemical cell.
ZA981842B (en) Treated horticultural substrates.
ZA98111B (en) Absorbent products having conforming means.
ZA9811836B (en) Belt pack.
HUP0002248A3 (en) Tablets, and process for making tablets
ZA985184B (en) Bleaching enzymes.
ZA975961B (en) Carrier for pastry.
EP0679402A3 (en) Biologically active substance-secreting hybrid gel.
ZA96960B (en) Anti-neurodegeneratively active 10-aminoaliphatyl-dibenz[b,f]oxepines
EP0674243A3 (en) Donor roll.
ZA9711103B (en) Plant support.
EP1002793A4 (en) Physiologically active substances tkr2449, process for producing the same, and microorganism
ZA9810759B (en) Proliferatively active product for treating proliferating cells.
ZA965191B (en) Cell treatment
ZA967385B (en) Stabilized absorbent article.
GB9714936D0 (en) Cell culture products
GB9912851D0 (en) Treating cells
AU6006800A (en) Treating cells